Stat
- STAT+: FDA to importer: keep your active pharma ingredients away from weed killer and antifreeze
- A heart attack app, misinfo crackdowns, and MRI-safe headphones
- STAT+: STAT+ Conversation: Dealing with the Delta variant
- STAT+: Pharmalittle: Sanofi to pay $3.2 billion to buy Translate Bio; COVAX struggles with Covid-19 vaccine distribution
- Opinion: Regulating digital health apps needs user-centered reform
NYT science news
- Climate Change Could Devastate Emperor Penguins, U.S. Officials Warn
- F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Month
- Is the Delta Variant Making Younger Adults ‘Sicker, Quicker’?
- How a Gecko From Africa Crossed the Atlantic Ocean
- In the Infrastructure Bill, a Recognition: Climate Change Is a Crisis
Fierce Biotech
- Lilly investors hungry for news on Alzheimer's drug get a clearer picture of Q4 FDA filing
- Baxter extends Amazon Web Services collaboration to support new digital health, data management projects
- Marinus hands over EU rights for antiseizure med to Orion in $30M upfront deal
- Scholar Rock's former CEO takes the helm again as Kingsley makes another swift exit
- Bausch Health’s aesthetics devicemaker Solta to go public in debt-reduction scheme
Fierce Medical Devices
- Baxter extends Amazon Web Services collaboration to support new digital health, data management projects
- Bausch Health’s aesthetics devicemaker Solta to go public in debt-reduction scheme
- Abbott subsidiary Alere pays $160M to settle false Medicare claims, diabetes kickbacks
- InterVenn Biosciences quintuples funding with $201M for AI-powered cancer tests
- FDA clears 3D hologram tech for ‘science-fiction’ surgical planning